Skip to content
healthcare.dev
Get a free key

CAVHANZA

NDC 70709-191, Nilotinib, tablet, orally disintegrating, from Cycle Pharmaceuticals Ltd.

Product NDC
70709-191
Status
Listed
Labeler
Cycle Pharmaceuticals Ltd
Dosage form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA217379
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70709-191 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NILOTINIB60 mg/1

Pharmacologic classes

Bcr-Abl Tyrosine Kinase Inhibitors [MoA]; Cytochrome P450 2B6 Inducers [MoA]; Cytochrome P450 2C8 Inducers [MoA]; Cytochrome P450 2C8 Inhibitors [MoA]; Cytochrome P450 2D6 Inhibitors [MoA]; Kinase Inhibitor [EPC]; P-Glycoprotein Inhibitors [MoA]; UGT1A1 Inhibitors [MoA]

Package NDCNDC-11Package
70709-191-1270709019112112 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (70709-191-12)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/98b197ea-bca4-427e-8737-97f70a3262bc

Use it

Look up 70709-191 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70709-191 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70709-191. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.